Wynzora (calcipotriene / betamethasone) is a topical cream used to treat plaque psoriasis in adults. It's a combination of 2 medications: calcipotriene (a form of vitamin D) and betamethasone (a corticosteroid). This medication is applied to the affected area once a day, for up to 2 months. Potential side effects include upper respiratory tract infection, headache, and irritation where you apply it. Wynzora (calcipotriene / betamethasone) is brand name only and not available as a generic medication.
Wynzora (calcipotriene / betamethasone) is a combination of two medications that help treat psoriasis.
Calcipotriene is a form of vitamin D. It works by slowing down the growth of skin cells to prevent skin patches in psoriasis.
Betamethasone is a topical corticosteroid (meaning it's applied to the outside of your body). It blocks swelling (inflammation) to relieve redness and itching.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
Applied just once a day
Combines two medications into one cream
Applied directly to the affected area(s)
Not an option for children
Not a long-term treatment for psoriasis
Brand name medication only
Wash your hands before and after you use Wynzora (calcipotriene / betamethasone), unless you're treating your hands.
Don't use Wynzora (calcipotriene / betamethasone) on areas of your body that have thinner skin, such as your face, underarms, or groin, unless your prescriber told you to do so.
If you accidentally get Wynzora (calcipotriene / betamethasone) in your eyes or on your face, wash the area well with water as soon as possible. If you continue to have irritation, contact your prescriber.
Don't cover any affected areas with bandages or dressings unless your prescriber tells you it's okay. This can cause more medication to be absorbed and can lead to more side effects.
Avoid spending too much time in the sunlight, tanning beds, and sunlamps, since Wynzora (calcipotriene / betamethasone) can make your skin more sensitive to the sun. If you need to be in the sun, you should wear sunscreen and protective clothing.
Don't take other medications containing calcipotriene or a corticosteroid at the same time as Wynzora (calcipotriene / betamethasone) without consulting your prescriber first. Doing so can cause more side effects.
Throw away Wynzora (calcipotriene / betamethasone) once it's been open for 6 months. It's unclear whether the medication will still work well or is safe to use after this time.
Speak to your prescriber about how long you should use Wynzora (calcipotriene / betamethasone). Typically, it should be used for the shortest time possible to treat your psoriasis symptoms, no longer than 2 month.
Tell your care team if you become pregnant while using Wynzora (calcipotriene / betamethasone). It's unclear whether this medication is safe to use during pregnancy. Based on animal studies of calcipotriene and on reports from people using high-potency topical corticosteroids, there's a chance that Wynzora (calcipotriene / betamethasone) might cause harm during pregnancy.
It's unclear whether Wynzora (calcipotriene / betamethasone) is safe to use during nursing. Talk with your dermatologist about the risks and benefits of using this medication if you're breastfeeding. If you choose to breastfeeding while using Wynzora (calcipotriene / betamethasone), avoid applying the medication to the nipple or area around it to lower your baby's risk of exposure to the medication.
Wynzora (calcipotriene / betamethasone) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Wynzora (calcipotriene / betamethasone) can cause high calcium levels in your blood or urine. Your healthcare team might order lab tests to check your calcium levels while you're taking this medication to make sure they're within a safe range. If your calcium levels are too high, they might ask you to stop this medication until the levels return to a safe range. If you have concerns, speak to your care team.
Risk factors: Using high potency (strong) corticosteroids | Large treatment areas | Long-term use | Using more than one corticosteroid product | Liver failure | Children | Broken skin | Using occlusive dressings
Wynzora contains betamethasone, a corticosteroid. This is a man-made version of cortisol, the stress hormone naturally made by the body. Using Wynzora (calcipotriene / betamethasone) for a long time can lead to symptoms of too much stress hormone, including weight gain and higher blood sugar levels. Children are at a higher risk, since more medication might be absorbed.
In addition, using Wynzora (calcipotriene / betamethasone) over a longer period of time can cause your body to stop making its own stress hormone. When you stop this medication, it takes a while for the body to ramp up making its own stress hormone again. During this time, you might experience topical steroid withdrawal symptoms, such as itchy or burning skin. If you need to stop Wynzora (calcipotriene / betamethasone), your healthcare team can help you do so safely by lowering your dose slowly over time.
Talk with your healthcare team if you're concerned about any of these side effects.
Some people can experience an allergic skin reaction to the ingredients in Wynzora (calcipotriene / betamethasone). Speak to your prescriber if you develop a skin rash from using Wynzora (calcipotriene / betamethasone), or if your symptoms aren't getting better.
Dosage | Quantity | Price as low as | Price per unit |
---|---|---|---|
60g of 0.005%/0.064% | 1 tube | $60.00 | $60.00 |
Wynzora cream contains calcipotriene 0.005% and betamethasone 0.064%.
Adults: Apply to the affected area(s) once a day for up to 8 weeks. Don't use more than 100 grams per week.
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
MC2 Therapeutics Ltd. (2023). Wynzora- calcipotriene and betamethasone dipropionate cream [package insert]. DailyMed.
McKenna, K. E., et al. (1995). Photosensitivity associated with combined UV-B and calcipotriene therapy. Archives of Dermatology.
Rogalski, C. (2015). Calcipotriol/betamethasone for the treatment of psoriasis: Efficacy, safety, and patient acceptability. Psoriasis.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.